Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

133 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy.
Jang HJ, Hostetter G, Macfarlane AW, Madaj Z, Ross EA, Hinoue T, Kulchycki JR, Burgos RS, Tafseer M, Alpaugh RK, Schwebel CL, Kokate R, Geynisman DM, Zibelman MR, Ghatalia P, Nichols PW, Chung W, Madzo J, Hahn NM, Quinn DI, Issa JJ, Topper MJ, Baylin SB, Shen H, Campbell KS, Jones PA, Plimack ER. Jang HJ, et al. Among authors: geynisman dm. Clin Cancer Res. 2023 Jun 1;29(11):2052-2065. doi: 10.1158/1078-0432.CCR-22-3642. Clin Cancer Res. 2023. PMID: 36928921 Free PMC article. Clinical Trial.
Testicular Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.
Gilligan T, Lin DW, Aggarwal R, Chism D, Cost N, Derweesh IH, Emamekhoo H, Feldman DR, Geynisman DM, Hancock SL, LaGrange C, Levine EG, Longo T, Lowrance W, McGregor B, Monk P, Picus J, Pierorazio P, Rais-Bahrami S, Saylor P, Sircar K, Smith DC, Tzou K, Vaena D, Vaughn D, Yamoah K, Yamzon J, Johnson-Chilla A, Keller J, Pluchino LA. Gilligan T, et al. Among authors: geynisman dm. J Natl Compr Canc Netw. 2019 Dec;17(12):1529-1554. doi: 10.6004/jnccn.2019.0058. J Natl Compr Canc Netw. 2019. PMID: 31805523
A review of economic impact of targeted oral anticancer medications.
Shen C, Chien CR, Geynisman DM, Smieliauskas F, Shih YC. Shen C, et al. Among authors: geynisman dm. Expert Rev Pharmacoecon Outcomes Res. 2014 Feb;14(1):45-69. doi: 10.1586/14737167.2014.868310. Epub 2013 Dec 30. Expert Rev Pharmacoecon Outcomes Res. 2014. PMID: 24378038 Review.
Using theory and user-centered design in digital health: The development of the mychoice communication tool to prepare patients and improve informed decision making regarding clinical trial participation.
Fleisher L, Bass SB, Shwarz M, Washington A, Nicholson A, Alhajji M, Geynisman DM, Maurer L, Greener J, Kenny C. Fleisher L, et al. Among authors: geynisman dm. Psychooncology. 2020 Jan;29(1):114-122. doi: 10.1002/pon.5254. Epub 2019 Dec 2. Psychooncology. 2020. PMID: 31654442
Reply to M.R. Litzow et al.
Geynisman DM. Geynisman DM. J Clin Oncol. 2013 Oct 10;31(29):3723-4. doi: 10.1200/JCO.2013.51.8431. Epub 2013 Sep 9. J Clin Oncol. 2013. PMID: 24019547 No abstract available.
133 results